A pilot study revealed that clinical IC/BPS patients who received repeated PRP intravesical injections once a month for four times showed a meaningful increased urinary IL-2 and IL-8 expression, indicating that PRP may ameliorate IC/BPS symptoms and enhance functional bladder capacity [50,51,52]. Here, CXCL8 is linked to Bartsocas-Papas syndrome 1.